The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72
Open accessAbstract
Intronic expansion of the GGGGCC hexanucleotide repeat within the C9ORF72 gene causes frontotemporal dementia and amyotrophic lateral sclerosis/motor neuron disease in both familial and sporadic cases. Initial reports indicate that this variant within the frontotemporal dementia/amyotrophic lateral sclerosis spectrum is associated with transactive response DNA binding protein (TDP-43) proteinopathy. The amyotrophic lateral sclerosis/motor neuron disease phenotype is not yet well characterized. We report the clinical and pathological phenotypes associated with pathogenic C9ORF72 mutations in a cohort of 563 cases from Northern England, including 63 with a family history of amyotrophic lateral sclerosis. One hundred and fifty-eight cases from the cohort (21 familial, 137 sporadic) were post-mortem brain and spinal cord donors. We screened DNA for the C9ORF72 mutation, reviewed clinical case histories and undertook pathological evaluation of brain and spinal cord. Control DNA samples (n = 361) from the same population were also screened. The C9ORF72 intronic expansion was present in 62 cases [11% of the cohort; 27/63 (43%) familial, 35/500 (7%) cases with sporadic amyotrophic lateral sclerosis/motor neuron disease]. Disease duration was significantly shorter in cases with C9ORF72-related amyotrophic lateral sclerosis (30.5 months) compared with non-C9ORF72 amyotrophic lateral sclerosis/motor neuron disease (36.3 months, P < 0.05). C9ORF72 cases included both limb and bulbar onset disease and all cases showed combined upper and lower motor neuron degeneration (amyotrophic lateral sclerosis). Thus, clinically, C9ORF72 cases show the features of a relatively rapidly progressive, but otherwise typical, variant of amyotrophic lateral sclerosis associated with both familial and sporadic presentations. Dementia was present in the patient or a close family member in 22/62 cases with C9ORF72 mutation (35%) based on diagnoses established from retrospective clinical case note review that may underestimate significant cognitive changes in late disease. All the C9ORF72 mutation cases showed classical amyotrophic lateral sclerosis pathology with TDP-43 inclusions in spinal motor neurons. Neuronal cytoplasmic inclusions and glial inclusions positive for p62 immunostaining in non-motor regions were strongly over-represented in the C9ORF72 cases. Extra-motor pathology in the frontal cortex (P < 0.0005) and the hippocampal CA4 subfield neurons (P < 0.0005) discriminated C9ORF72 cases strongly from the rest of the cohort. Inclusions in CA4 neurons were not present in non-C9ORF72 cases, indicating that this pathology predicts mutation status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433 · cited 1×
“All 563 cases were reviewed by a senior consultant neurologist (C.J.M. or P.J.S.) and diagnosed with definite or probable ALS, as defined by the El Escorial criteria (Brooks et al., 2000).”
MethodDeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citationTDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Elden, A. C., Kim, H.-J., Hart, M. P., Chen-Plotkin, A. S., Johnson, B. S., Fang, X., Armakola, M., Geser, F., Greene, R., Lu, M. M., et al. (2010) · Nature · doi:10.1038/nature09320 · Cited by 1,325
Mutations of optineurin in amyotrophic lateral sclerosis
Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., et al. (2010) · Nature · doi:10.1038/nature08971 · Cited by 1,265
Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Johnson, J. O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V. M., Trojanowski, J. Q., Gibbs, J. R., Brunetti, M., Gronka, S., Wuu, J., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.036 · Cited by 1,235 · cited 1×
“In particular, mutations in the VCP gene appear to cause a clinical spectrum including inclusion body myositis, FTD and Paget's disease (Johnson et al., 2010).”
BackgroundSelf-citationA harmonized classification system for FTLD-TDP pathology
Mackenzie, I. R. A., Neumann, M., Baborie, A., Sampathu, D. M., Du Plessis, D., Jaros, E., Perry, R. H., Trojanowski, J. Q., Mann, D. M. A., & Lee, V. M. Y. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0845-8 · Cited by 1,017
Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S. L., Wyns, S., Thijs, V., Andersson, J., van Marion, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1211 · Cited by 860
Buratti, E., & Baralle, F. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104236200 · Cited by 700
The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study
Phukan, J., Elamin, M., Bede, P., Jordan, N., Gallagher, L., Byrne, S., Lynch, C., Pender, N., & Hardiman, O. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300188 · Cited by 667
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis
Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., & Shaw, P. J. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.152 · Cited by 615 · cited 2×
“ALS is thought to be the common end-point of various disease mechanisms (Ferraiuolo et al., 2011) and it is possible that only some of these mechanisms result in an associated dementia.”
BackgroundSelf-citationCognitive impairment in amyotrophic lateral sclerosis
Phukan, J., Pender, N. P., & Hardiman, O. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70265-x · Cited by 609
van Es, M. A., Veldink, J. H., Saris, C. G. J., Blauw, H. M., van Vught, P. W. J., Birve, A., Lemmens, R., Schelhaas, H. J., Groen, E. J. N., Huisman, M. H. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.442 · Cited by 399
Fugier, C., Klein, A. F., Hammer, C., Vassilopoulos, S., Ivarsson, Y., Toussaint, A., Tosch, V., Vignaud, A., Ferry, A., Messaddeq, N., et al. (2011) · Nature Medicine · doi:10.1038/nm.2374 · Cited by 335
Hosler, B. A. (2000) · JAMA · doi:10.1001/jama.284.13.1664 · Cited by 315
Genetics of familial amyotrophic lateral sclerosis
Valdmanis, P. N., & Rouleau, G. A. (2008) · Neurology · doi:10.1212/01.wnl.0000296811.19811.db · Cited by 281
Clinical and Pathological Continuum of Multisystem TDP-43 Proteinopathies
Geser, F., Martinez-Lage, M., Robinson, J., Uryu, K., Neumann, M., Brandmeir, N. J., Xie, S. X., Kwong, L. K., Elman, L., McCluskey, L., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.558 · Cited by 267
Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study
Laaksovirta, H., Peuralinna, T., Schymick, J. C., Scholz, S. W., Lai, S.-L., Myllykangas, L., Sulkava, R., Jansson, L., Hernandez, D. G., Gibbs, J. R., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70184-8 · Cited by 259
Self-citationRNA‐mediated neurodegeneration in repeat expansion disorders
Todd, P. K., & Paulson, H. L. (2010) · Annals of Neurology · doi:10.1002/ana.21948 · Cited by 226
Frontotemporal dementia and motor neurone disease: Overlapping clinic-pathological disorders
Lillo, P., & Hodges, J. R. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.03.005 · Cited by 195
Nishihira, Y., Tan, C.-F., Onodera, O., Toyoshima, Y., Yamada, M., Morita, T., Nishizawa, M., Kakita, A., & Takahashi, H. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0385-z · Cited by 187 · cited 1×
“The subdivision of ALS cases into two subgroups on the basis of neuropathological involvement of extra-motor (principally hippocampal and frontotemporal neocortex) has been described elsewhere (Nishihira et al., 2008).”
BackgroundBose, J. K., Wang, I.-F., Hung, L., Tarn, W.-Y., & Shen, C.-K. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805376200 · Cited by 172
Mackenzie, I. R. A., & H. Feldman, H. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000174335.27708.0a · Cited by 161
Novel FUS/TLS Mutations and Pathology in Familial and Sporadic Amyotrophic Lateral Sclerosis
Hewitt, C., Kirby, J., Highley, J. R., Hartley, J. A., Hibberd, R., Hollinger, H. C., Williams, T. L., Ince, P. G., McDermott, C. J., & Shaw, P. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.52 · Cited by 160
Self-citationInce, P. G., Tomkins, J., Slade, J. Y., Thatcher, N. M., & Shaw, P. J. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199810000-00002 · Cited by 142
Self-citationThe chromosome 9 ALS and FTD locus is probably derived from a single founder
Mok, K., Traynor, B. J., Schymick, J., Tienari, P. J., Laaksovirta, H., Peuralinna, T., Myllykangas, L., Chiò, A., Shatunov, A., Boeve, B. F., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.005 · Cited by 131 · cited 1×
“nucleotide polymorphism common haplotype spanning a 140-kb segment (Mok et al., 2011).”
BackgroundSelf-citationGenetics of familial Amyotrophic lateral sclerosis.
Ticozzi, N., Tiloca, C., Morelli, C., Colombrita, C., Poletti, B., Doretti, A., Maderna, L., Messina, S., Ratti, A., & Silani, V. (2011) · PubMed · doi:10.4449/aib.v149i1.1262 · Cited by 121
Kirby, J., Goodall, G., Smith, W., Highley, J. R., Masanzu, R., Hartley, J. A., Hibberd, R., Hollinger, H. C., Wharton, S. B., Morrison, K. E., et al. (2009) · Neurogenetics · doi:10.1007/s10048-009-0218-9 · Cited by 95
Self-citationFecto, F., & Siddique, T. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9637-9 · Cited by 80
Takeda, T., Uchihara, T., Arai, N., Mizutani, T., & Iwata, M. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0447-2 · Cited by 77
Genetics of Familial Amyotrophic Lateral Sclerosis
Emily, F., Joanna, J., Cooper‐Knock, J., Pamela, J., & Kirby, J. (2012) · InTech eBooks · doi:10.5772/32498 · Cited by 60
Self-citationYanagihara, R., Garruto, R. M., & Gajdusek, D. C. (1983) · Annals of Neurology · doi:10.1002/ana.410130117 · Cited by 49
Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases
Mackenzie, I. R., & Feldman, H. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0678-1 · Cited by 41
Family history of neurodegenerative and vascular diseases in ALS: A population-based study
Huisman, M. H. B., de Jong, S. W., Verwijs, M. C., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., Veldink, J. H., & van den Berg, L. H. (2011) · Neurology · doi:10.1212/wnl.0b013e318231530b · Cited by 39
Familial risks for amyotrophic lateral sclerosis and autoimmune diseases
Hemminki, K., Li, X., Sundquist, J., & Sundquist, K. (2008) · Neurogenetics · doi:10.1007/s10048-008-0164-y · Cited by 33
Optineurin coding variants in Ghanaian patients with primary open-angle glaucoma.
Liu, Y., Akafo, S., Santiago-Turla, C., Cohen, C. S., Larocque-Abramson, K. R., Qin, X., Herndon, L. W., Challa, P., Schmidt, S., Hauser, M. A., et al. (2008) · PubMed Central · Cited by 23
The Concurrence of Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Hader, W. J., Rozdilsky, B., & Nair, C. P. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100035824 · Cited by 20
Cited by
Decoding ALS: from genes to mechanism
Taylor, J. P., Brown, R. H., & Cleveland, D. W. (2016) · Nature · doi:10.1038/nature20413 · Cited by 2,066
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811
Byrne, S., Elamin, M., Bede, P., Shatunov, A., Walsh, C., Corr, B., Heverin, M., Jordan, N., Kenna, K., Lynch, C., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70014-5 · Cited by 484
Advances in understanding the molecular basis of frontotemporal dementia
Rademakers, R., Neumann, M., & Mackenzie, I. R. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.117 · Cited by 412
The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy
Webster, C. P., Smith, E. F., Bauer, C. S., Moller, A., Hautbergue, G. M., Ferraiuolo, L., Myszczynska, M. A., Higginbottom, A., Walsh, M. J., Whitworth, A. J., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201694401 · Cited by 404
Self-citation
Metadata
- Authors
- Cooper-Knock, J., Hewitt, C., Highley, J. R., Brockington, A., Milano, A., Man, S., Martindale, J., Hartley, J., Walsh, T., Gelsthorpe, C., Baxter, L., Forster, G., Fox, M., Bury, J., Mok, K., McDermott, C. J., Traynor, B. J., Kirby, J., Wharton, S. B., Ince, P. G., Hardy, J., & Shaw, P. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-02-24
- Volume
- 135
- Issue
- 3
- Pages
- 751-764
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W1995222212
- Cited by
- 330
- References
- 38
- FWCI
- 24.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.